| Title |
Adverse drug reactions monitoring: prospects and impending challenges for pharmacovigilance
|
|---|---|
| Published in |
SpringerPlus, November 2014
|
| DOI | 10.1186/2193-1801-3-695 |
| Pubmed ID | |
| Authors |
Ram Kumar Sahu, Rajni Yadav, Pushpa Prasad, Amit Roy, Shashikant Chandrakar |
| Abstract |
Pharmacovigilance plays a consequential role in the surveillance of adverse drug reactions, which is provoked by the drugs used to cure diseases. Adverse drug reactions (ADRs) produce detrimental or undesirable effects to the body after administration of drugs. It has been reported that the number of patients dying because of contrary effects of drugs per year increased upto 2.6-fold. Moreover, rates of hospitalization of patients are increasing owing to adverse effects of drugs. Thus, it becomes challengeable for physician, health care providers, WHO and pharmaceutical industries to resolve the associated problem of ADRs. During the clinical trial of a novel drug, it is prominent to explore the dependability of drug. In this review, we documented the details required to identify the ADRs in patients along with reported banned drugs. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Scientists | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 135 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 135 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 20 | 15% |
| Student > Bachelor | 14 | 10% |
| Student > Ph. D. Student | 12 | 9% |
| Researcher | 11 | 8% |
| Other | 8 | 6% |
| Other | 24 | 18% |
| Unknown | 46 | 34% |
| Readers by discipline | Count | As % |
|---|---|---|
| Pharmacology, Toxicology and Pharmaceutical Science | 38 | 28% |
| Medicine and Dentistry | 22 | 16% |
| Biochemistry, Genetics and Molecular Biology | 7 | 5% |
| Nursing and Health Professions | 5 | 4% |
| Agricultural and Biological Sciences | 5 | 4% |
| Other | 13 | 10% |
| Unknown | 45 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 November 2014.
All research outputs
#18,384,336
of 22,771,140 outputs
Outputs from SpringerPlus
#1,261
of 1,852 outputs
Outputs of similar age
#262,154
of 361,946 outputs
Outputs of similar age from SpringerPlus
#57
of 80 outputs
Altmetric has tracked 22,771,140 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,852 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.7. This one is in the 21st percentile – i.e., 21% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 361,946 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 16th percentile – i.e., 16% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 80 others from the same source and published within six weeks on either side of this one. This one is in the 15th percentile – i.e., 15% of its contemporaries scored the same or lower than it.